tradingkey.logo
tradingkey.logo
検索

Envista Holdings Corp

NVST
ウォッチリストに追加
24.910USD
-0.350-1.39%
終値 06/23, 16:00ET15分遅れの株価
4.11B時価総額
60.54直近12ヶ月PER

詳細情報 Envista Holdings Corp 企業名

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

Envista Holdings Corpの企業情報

企業コードNVST
会社名Envista Holdings Corp
上場日Sep 18, 2019
最高経営責任者「CEO」Keel (Paul A)
従業員数12300
証券種類Ordinary Share
決算期末Sep 18
本社所在地200 S. Kraemer Blvd., Bldg. E
都市BREA
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号92821
電話番号17148175418
ウェブサイトhttps://envistaco.com/en
企業コードNVST
上場日Sep 18, 2019
最高経営責任者「CEO」Keel (Paul A)

Envista Holdings Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
154.81K
-8.28%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
49.49K
+18.85%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
49.48K
+18.86%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
43.56K
+21.42%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
42.49K
+21.96%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
11.75K
-381.11%
Mr. Mischa M. Reis
Mr. Mischa M. Reis
Senior Vice President - Strategy and Corporate Development
Senior Vice President - Strategy and Corporate Development
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
154.81K
-8.28%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
49.49K
+18.85%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
49.48K
+18.86%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
43.56K
+21.42%

よくある質問

Envista Holdings Corpの上位5名の株主は誰ですか?

Envista Holdings Corpの上位5名の株主は以下のとおりです。Mr. Paul A. Keel

Envista Holdings Corp(NVST)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Envista Holdings Corpの株式を保有している機関は711社あり、保有株式の総市場価値は約203.45Mで、全体の125.03%を占めています。2025Q4と比較して、機関の持ち株は-3285874.00増加しています。
KeyAI